RAD Media

Telix sp move and most likely our short-lived sp increase as well is based on this:

Telix Welcomes CMS Proposal to Improve Payment for Specialised
Diagnostic Radiopharmaceuticals
Melbourne (Australia) – 11 July 2024. Telix Pharmaceuticals Limited (ASX: TLX, Telix, the
Company) today welcomes proposed changes announced by the Centers for Medicare & Medicaid
Services (CMS) for the Hospital Outpatient Prospective Payment System (OPPS) rule to improve
payments for diagnostic radiopharmaceuticals1
for Medicare patients in the United States (U.S.),
facilitating continued patient access after transitional pass-through payment status expires.
Under the proposed changes, diagnostic radiopharmaceuticals including Illuccix® will continue to be
paid separately by CMS for traditional Medicare Fee for Service patients in the hospital outpatient
setting following the expiry of transitional pass-through payment status. This would also apply to new
diagnostic products being developed by Telix, if approved.
Currently in the U.S., the costs associated with diagnostic radiopharmaceuticals are packaged
together into the payment for the nuclear medicine tests (scans). The CMS is proposing refinements
to this policy to improve the accuracy of overall payment amounts by paying separately for any
diagnostic radiopharmaceutical with a per day cost greater than US$630.
Kevin Richardson, CEO of Telix Americas commented: “Telix welcomes the proposed rule, which
will facilitate more equitable and reliable access to advanced imaging for all patients and support
physicians to prescribe the most clinically appropriate solution. We commend the vision of CMS and
the coalition, along with patient groups, for raising awareness about the necessity to reform the
payment system to enhance patient outcomes and access. Telix is committed to continued
innovation in the field of radiopharmaceutical diagnostics to provide new solutions to further patient
access, especially for underserved patient populations and in areas of high unmet clinical need.”
Proposed OPPS rules are published annually and have a 60-day comment period, which will end
on 9 September 2024. The final rule will be issued in early November 2024 and take effect 1
January 2025.


Maybe Lantheus was already aware of that. At some stage the US investors and some Telix holders will grab that little bargain.

GLTA